LOTRONEX Side Effects

6968150-3 | Renal Atrophy, Renal Hypertrophy, Small Intestinal Obstruction
on Aug 18, 2010 Female patient from UNITED STATES , 52 years of age, weighting 145.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). Patient experienced the following unwanted or unexpected effects: renal atrophy, renal hypertrophy, small intestinal obstruction. Lotronex dosage: 1.0 Mg;bid;po. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), BENICAR (View Benicar Review and Benicar Label ). Patient was hospitalized.

6925040-X | Cholecystectomy, Colitis Ischaemic, Coronary Arterial Stent Insertion, Knee Arthroplasty
Patient was taking Lotronex (View Usage). Patient had the following side effects: cholecystectomy, colitis ischaemic, coronary arterial stent insertion, knee arthroplasty on Aug 02, 2010 from UNITED STATES Additional patient health information: Female patient , 63 years of age, weighting 185.0 lb, was diagnosed with diarrhoea, irritable bowel syndrome (What is irritable bowel syndrome?) and. Lotronex dosage: 1.0 Mg;bid. During the same period patient was treated with ESTRATEST (View Estratest Review and Estratest Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), ALTACE (View Altace Review and Altace Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), AMBIEN (View Ambien Review and Ambien Label ), MAXAIR (View Maxair Review and Maxair Label ), WELCHOL (View Welchol Review and Welchol Label ). Patient was hospitalized.

6914529-5 |
Adverse event was reported on Jul 27, 2010 by a Female patient taking Lotronex (View Usage) (Dosage: 0.5 Mg;bid) was diagnosed with diarrhoea, irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED STATES , 45 years of age, weighting 138.0 lb, . During the same period patient was treated with LOMOTIL /00034001/ (View Lomotil /00034001/ Review and Lomotil /00034001/ Label ).

6829825-X |
on Jun 17, 2010 Female patient from UNITED STATES , 45 years of age, was treated with Lotronex (View Usage). . Lotronex dosage: 0.5 Mg; Bid.


6816454-7 | Colitis, Diarrhoea Haemorrhagic
on Jun 23, 2010 Female patient from UNITED STATES , 23 years of age, weighting 99.00 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). Patient had the following side effects: colitis, diarrhoea haemorrhagic. Lotronex dosage: 0.5 Mg;qd;po. During the same period patient was treated with DESLORATADINE (View Desloratadine Review and Desloratadine Label ), MICROGESTIN 1.5/30 (View Microgestin 1.5/30 Review and Microgestin 1.5/30 Label ), TOPAMAX (View Topamax Review and Topamax Label ).

6776204-X | Colitis Ischaemic
Patient was taking Lotronex (View Usage). After Lotronex was administered, patient had the following side effects: colitis ischaemic on Jun 01, 2010 from UNITED STATES Additional patient health information: Female patient , 23 years of age, weighting 99.00 lb, was diagnosed with abdominal pain (What is abdominal pain?), diarrhoea, irritable bowel syndrome (What is irritable bowel syndrome?) and. Lotronex dosage: 0.5 Mg;qd;po. During the same period patient was treated with DESLORATADINE (View Desloratadine Review and Desloratadine Label ), MICROGESTIN FE (View Microgestin Fe Review and Microgestin Fe Label ), TOPAMAX (View Topamax Review and Topamax Label ).

6765387-3 | Aphasia, Asthenia, Bradyphrenia, Cyanosis, Dehydration, Diarrhoea, Dysphemia, Fall, Heart Rate Increased
Adverse event was reported on May 26, 2010 by a Female patient taking Lotronex (View Usage) (Dosage: 1 Mg;prn;po) was diagnosed with diarrhoea and. Location: UNITED STATES , 53 years of age, weighting 150.0 lb, Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), asthenia, bradyphrenia, cyanosis, dehydration, diarrhoea, dysphemia, fall (What is fall?), heart rate increased. During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), POTASSIUM (View Potassium Review and Potassium Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

6755008-8 | Cardiac Disorder, Deep Vein Thrombosis, Palpitations, Platelet Count Increased
on May 21, 2010 Female patient from UNITED STATES , 47 years of age, weighting 188.0 lb, was diagnosed with abdominal distension, irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). Patient had the following side effects: cardiac disorder, deep vein thrombosis (What is deep vein thrombosis?), palpitations, platelet count increased. Lotronex dosage: 0.5 Mg; Qd;. During the same period patient was treated with DYAZIDE (View Dyazide Review and Dyazide Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6738967-9 | Abdominal Pain, Colitis Ischaemic
on May 09, 2010 Female patient from UNITED STATES , 23 years of age, was treated with Lotronex (View Usage). After Lotronex was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), colitis ischaemic. Lotronex dosage: 0.5m G;qd;po.

6732987-6 | Colitis Ischaemic, Diarrhoea Haemorrhagic, Irritable Bowel Syndrome
Patient was taking Lotronex (View Usage). Patient experienced the following unwanted or unexpected effects: colitis ischaemic, diarrhoea haemorrhagic, irritable bowel syndrome (What is irritable bowel syndrome?) on May 04, 2010 from UNITED STATES Additional patient health information: Female patient , 38 years of age, weighting 180.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Lotronex dosage: 1 Mg; Qd;po. During the same period patient was treated with CELEXA (View Celexa Review and Celexa Label ), ORTHO NOVUM (View Ortho-novum Review and Ortho-novum Label ), XYZAL (View Xyzal Review and Xyzal Label ), AZELASTINE HCL (View Azelastine Hcl Review and Azelastine Hcl Label ), AMERGE (View Amerge Review and Amerge Label ).

6730174-9 | Crohn's Disease, Disease Recurrence, Refusal Of Treatment By Patient, Septic Shock, Small Intestinal Perforation
Adverse event was reported on May 11, 2010 by a Female patient taking Lotronex (View Usage) (Dosage: 1 Mg;qd) was diagnosed with inflammatory bowel disease, irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED STATES , 60 years of age, weighting 285.0 lb, Patient had the following side effects: crohn's disease (What is crohn's disease?), disease recurrence, refusal of treatment by patient, septic shock, small intestinal perforation. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), COUMADIN (View Coumadin Review and Coumadin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ). Patient was hospitalized.

6718493-3 | Colitis Ischaemic
on Apr 20, 2010 Female patient from UNITED STATES , 38 years of age, weighting 180.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). After Lotronex was administered, patient had the following side effects: colitis ischaemic. Lotronex dosage: 1 Mg; Qd;po.

6701825-X | Colitis Ischaemic, Weight Decreased
on Apr 13, 2010 Female patient from UNITED STATES , 44 years of age, weighting 189.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). Patient experienced the following unwanted or unexpected effects: colitis ischaemic, weight decreased. Lotronex dosage: 0.5 Mg;bid. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ZOCOR (View Zocor Review and Zocor Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ).

6680367-4 | Arthralgia, Intestinal Perforation, Oropharyngeal Pain, Septic Shock
Patient was taking Lotronex (View Usage). Patient had the following side effects: arthralgia, intestinal perforation, oropharyngeal pain, septic shock on Mar 29, 2010 from UNITED STATES Additional patient health information: Female patient , 60 years of age, weighting 285.0 lb, was diagnosed with inflammatory bowel disease, irritable bowel syndrome (What is irritable bowel syndrome?) and. Lotronex dosage: 1mg;qd. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), COUMADIN (View Coumadin Review and Coumadin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ). Patient was hospitalized.

6627819-0 | Cyanosis, Dehydration, Diarrhoea, Dysphemia, Fall, Intestinal Obstruction, Malaise, Po2 Decreased, Pulmonary Embolism
Adverse event was reported on Feb 22, 2010 by a Female patient taking Lotronex (View Usage) (Dosage: 1mg; Prn; Po) was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED STATES , 53 years of age, weighting 150.0 lb, After Lotronex was administered, patient had the following side effects: cyanosis, dehydration, diarrhoea, dysphemia, fall (What is fall?), intestinal obstruction, malaise, po2 decreased, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), POTASSIUM (View Potassium Review and Potassium Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

6595274-5 | Cardiac Failure Congestive, Hepatitis, Mononucleosis Syndrome, Pulmonary Embolism
on Jan 28, 2010 Female patient from UNITED STATES , 51 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, hepatitis (What is hepatitis?), mononucleosis syndrome, pulmonary embolism (What is pulmonary embolism?). Lotronex dosage: 0.5 Mg; Bid; Po. During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), CELEBREXA (View Celebrexa Review and Celebrexa Label ). Patient was hospitalized.

6545429-0 | Disease Complication, Gastritis, Haematemesis, Hepatic Cirrhosis, Liver Injury
on Jan 07, 2010 Female patient from UNITED STATES , 53 years of age, weighting 130.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). Patient had the following side effects: disease complication, gastritis, haematemesis, hepatic cirrhosis, liver injury. Lotronex dosage: 1 Mg;qd. Patient was hospitalized.

6521205-X | Disease Complication, Fluid Retention, Haematemesis, Hepatic Cirrhosis, Liver Disorder
Patient was taking Lotronex (View Usage). After Lotronex was administered, patient had the following side effects: disease complication, fluid retention, haematemesis, hepatic cirrhosis, liver disorder on Dec 10, 2009 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 130.0 lb, was diagnosed with diarrhoea, irritable bowel syndrome (What is irritable bowel syndrome?) and. Lotronex dosage: 1 Mg;qd. Patient was hospitalized.

6491784-X | Abdominal Distension, Abdominal Pain, Diverticulitis, Nausea, Pyrexia, Rectal Haemorrhage
Adverse event was reported on Nov 25, 2009 by a Female patient taking Lotronex (View Usage) (Dosage: 0.5 Mg;bid;po) was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED STATES , 66 years of age, weighting 125.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain (What is abdominal pain?), diverticulitis, nausea (What is nausea?), pyrexia, rectal haemorrhage. During the same period patient was treated with VAGIFEM (View Vagifem Review and Vagifem Label ), ESTROGEN PATCH (View Estrogen Patch Review and Estrogen Patch Label ). Patient was hospitalized.

6468217-2 | Haematemesis
on Nov 13, 2009 Female patient from UNITED STATES , 53 years of age, weighting 130.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). Patient had the following side effects: haematemesis. Lotronex dosage: 1 Mg; Qd. Patient was hospitalized.

6462141-7 | Colitis Ischaemic
on Nov 10, 2009 Female patient from UNITED STATES , 66 years of age, weighting 125.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). After Lotronex was administered, patient had the following side effects: colitis ischaemic. Lotronex dosage: 0.5 Mg;bid;po. During the same period patient was treated with VAGIFEM (View Vagifem Review and Vagifem Label ), ESTROGEN PATCH (View Estrogen Patch Review and Estrogen Patch Label ). Patient was hospitalized.

6443268-2 | Abdominal Pain, Colitis Ischaemic, Rectal Haemorrhage
Patient was taking Lotronex (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), colitis ischaemic, rectal haemorrhage on Oct 30, 2009 from UNITED STATES Additional patient health information: Female patient , 55 years of age, weighting 177.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Lotronex dosage: 1.0 Mg; Bid. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ).

6357177-0 | Asthenia, Coeliac Disease, Colitis Ischaemic, Constipation, Dehydration, Fatigue, Gastritis, Intestinal Polyp, Large Intestinal Ulcer
Adverse event was reported on Aug 19, 2009 by a Female patient taking Lotronex (View Usage) (Dosage: 0.5 Mg; Bid) was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED STATES , 31 years of age, weighting 195.0 lb, Patient had the following side effects: asthenia, coeliac disease, colitis ischaemic, constipation (What is constipation?), dehydration, fatigue, gastritis, intestinal polyp, large intestinal ulcer. During the same period patient was treated with ULTRACLEAR PLUS (View Ultraclear Plus Review and Ultraclear Plus Label ), PRENATAL (View Prenatal Review and Prenatal Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), MULTI MINERALS (View Multi Minerals Review and Multi Minerals Label ), CONJUGATED LINOLEIC (View Conjugated Linoleic Review and Conjugated Linoleic Label ), ACID (View Acid Review and Acid Label ), ANTIOXIDANTS (View Antioxidants Review and Antioxidants Label ), VITAMIN B 12 SL (View Vitamin B-12 Sl Review and Vitamin B-12 Sl Label ). Patient was hospitalized.

6337088-7 | Disease Complication, Haematemesis, Hepatic Cirrhosis
on Aug 19, 2009 Female patient from UNITED STATES , 53 years of age, weighting 130.0 lb, was treated with Lotronex (View Usage). After Lotronex was administered, patient had the following side effects: disease complication, haematemesis, hepatic cirrhosis. Lotronex dosage: 1 Mg; Qd. Patient was hospitalized.

6337087-5 | Colitis Ischaemic, Gastric Ulcer, Gastritis, Hypervigilance, Overweight, Pregnancy
on Aug 19, 2009 Female patient from UNITED STATES , 31 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). Patient experienced the following unwanted or unexpected effects: colitis ischaemic, gastric ulcer, gastritis, hypervigilance, overweight, pregnancy (What is pregnancy?). Lotronex dosage: 0.5 Mg; Bid;. Patient was hospitalized.

6318438-4 | Antigliadin Antibody Positive, Colitis, Faecaloma, Insomnia, Obstruction, Weight Increased
Patient was taking Lotronex (View Usage). Patient had the following side effects: antigliadin antibody positive, colitis, faecaloma, insomnia, obstruction, weight increased on Aug 07, 2009 from UNITED STATES Additional patient health information: Female patient , 27 years of age, weighting 270.0 lb, was diagnosed with diarrhoea and. Lotronex dosage: 1 Mg; Bid. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), VALIUM (View Valium Review and Valium Label ), NORCO (View Norco Review and Norco Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), JANUVIA (View Januvia Review and Januvia Label ), PRINIVIL (View Prinivil Review and Prinivil Label ). Patient was hospitalized.

6312876-1 | Colitis Ischaemic, Incorrect Dose Administered, Osteonecrosis
Adverse event was reported on Jul 31, 2009 by a Female patient taking Lotronex (View Usage) (Dosage: 1.0 Mg; Qd; Po) was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED STATES , 61 years of age, weighting 150.0 lb, After Lotronex was administered, patient had the following side effects: colitis ischaemic, incorrect dose administered, osteonecrosis (What is osteonecrosis?). During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), VIVELLE DOT (View Vivelle-dot Review and Vivelle-dot Label ), LIPITOR (View Lipitor Review and Lipitor Label ), XYZAL (View Xyzal Review and Xyzal Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), BONIVA (View Boniva Review and Boniva Label ). Patient was hospitalized.

6312613-0 | Colitis Ischaemic
on Jul 29, 2009 Female patient from UNITED STATES , 32 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). Patient experienced the following unwanted or unexpected effects: colitis ischaemic. Lotronex dosage: 0.5 Mb;qd. Patient was hospitalized.

6287531-7 | Obstruction
on Jul 10, 2009 Female patient from UNITED STATES , 27 years of age, was treated with Lotronex (View Usage). Patient had the following side effects: obstruction. Lotronex dosage: . Patient was hospitalized.

6259107-9 | Colitis Ischaemic, Osteonecrosis
Patient was taking Lotronex (View Usage). After Lotronex was administered, patient had the following side effects: colitis ischaemic, osteonecrosis (What is osteonecrosis?) on Jun 18, 2009 from UNITED STATES Additional patient health information: Female patient , 61 years of age, weighting 150.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Lotronex dosage: 1.0 Mg;qd;po. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), VIVELLE DOT (View Vivelle-dot Review and Vivelle-dot Label ), LIPITOR (View Lipitor Review and Lipitor Label ), XYZAL (View Xyzal Review and Xyzal Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ). Patient was hospitalized.

6237750-0 | Blood Glucose Increased, Blood Lactic Acid Increased, Blood Urea Decreased, Colitis Ischaemic, Diverticulum, Hepatic Steatosis, Lipase Increased, Scan Abdomen Abnormal, Uterine Disorder
Adverse event was reported on Jun 11, 2009 by a Female patient taking Lotronex (View Usage) (Dosage: 1 Mg; Bid; Po) was diagnosed with diarrhoea, irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED STATES , 53 years of age, weighting 168.0 lb, Patient experienced the following unwanted or unexpected effects: blood glucose increased, blood lactic acid increased, blood urea decreased, colitis ischaemic, diverticulum, hepatic steatosis, lipase increased, scan abdomen abnormal, uterine disorder. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), LOTENSIN (View Lotensin Review and Lotensin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), COLESTID (View Colestid Review and Colestid Label ), VYTORIN (View Vytorin Review and Vytorin Label ), LOMOTIL (View Lomotil Review and Lomotil Label ), CELEXA (View Celexa Review and Celexa Label ). Patient was hospitalized.

6212885-7 | Colitis Ischaemic
on May 15, 2009 Female patient from UNITED STATES , 60 years of age, was diagnosed with diarrhoea, inflammatory bowel disease and was treated with Lotronex (View Usage). Patient had the following side effects: colitis ischaemic. Lotronex dosage: 1 Mg;qd;po. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZIAC (View Ziac Review and Ziac Label ), PREMARIN (View Premarin Review and Premarin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), IMODIUM (View Imodium Review and Imodium Label ).

6195839-9 | Abdominal Discomfort, Abdominal Pain, Abdominal Pain Upper, Blood Glucose Increased, Blood Lactic Acid Increased, Blood Urea Decreased, Computerised Tomogram Abnormal, Constipation, Diverticulum Intestinal
on Apr 29, 2009 Female patient from UNITED STATES , 53 years of age, weighting 168.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). After Lotronex was administered, patient had the following side effects: abdominal discomfort, abdominal pain (What is abdominal pain?), abdominal pain upper, blood glucose increased, blood lactic acid increased, blood urea decreased, computerised tomogram abnormal, constipation (What is constipation?), diverticulum intestinal. Lotronex dosage: 1 Mg;bid;po. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), LOTENSIN (View Lotensin Review and Lotensin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), COLESTID (View Colestid Review and Colestid Label ), VYTORIN (View Vytorin Review and Vytorin Label ), LOMOTIL (View Lomotil Review and Lomotil Label ), CELEXA (View Celexa Review and Celexa Label ), JANUVIA (View Januvia Review and Januvia Label ). Patient was hospitalized.

6193626-9 | Colitis Ischaemic
Patient was taking Lotronex (View Usage). Patient experienced the following unwanted or unexpected effects: colitis ischaemic on Apr 30, 2009 from UNITED STATES Additional patient health information: Female patient , 59 years of age, . Lotronex dosage: .

6169261-5 | Abdominal Pain, Anal Sphincter Atony, Body Temperature Increased, Chromaturia, Diarrhoea, Diarrhoea Haemorrhagic, Diverticulum Intestinal, Excoriation, Haemorrhoids
Adverse event was reported on Apr 08, 2009 by a Female patient taking Lotronex (View Usage) (Dosage: 0.5 Mg;qd;po) was diagnosed with diarrhoea and. Location: UNITED STATES , 70 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), anal sphincter atony, body temperature increased, chromaturia, diarrhoea, diarrhoea haemorrhagic, diverticulum intestinal, excoriation, haemorrhoids. During the same period patient was treated with PRIMIDONE (View Primidone Review and Primidone Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), SANZOZ (View Sanzoz Review and Sanzoz Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), CHROMIUM PICOLINATE (View Chromium Picolinate Review and Chromium Picolinate Label ), EFFEXOR (View Effexor Review and Effexor Label ), FEXOFENADINE (View Fexofenadine Review and Fexofenadine Label ), FOSAMAX (View Fosamax Review and Fosamax Label ).

6109505-9 | Adhesion, Anaemia, Cardiovascular Insufficiency, Colitis Ischaemic, Condition Aggravated, Culture Positive, Electrolyte Imbalance, Haemorrhoids, Ileus Paralytic
on Feb 20, 2009 Female patient from UNITED STATES , 60 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). After Lotronex was administered, patient had the following side effects: adhesion (What is adhesion?), anaemia, cardiovascular insufficiency, colitis ischaemic, condition aggravated, culture positive, electrolyte imbalance, haemorrhoids, ileus paralytic. Lotronex dosage: 0.5 Mg; Biw; Po. During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), MAXZIDE (View Maxzide Review and Maxzide Label ), RELAFEN (View Relafen Review and Relafen Label ), METROGEL (View Metrogel Review and Metrogel Label ), NULEV (View Nulev Review and Nulev Label ), DARVOCET (View Darvocet Review and Darvocet Label ), DONNATAI (View Donnatai Review and Donnatai Label ), TRIAMTERENE (View Triamterene Review and Triamterene Label ). Patient was hospitalized.

6012874-1 | Abdominal Pain Lower, Acidosis, Anaemia, Blood Alkaline Phosphatase Increased, Blood Calcium Increased, Blood Electrolytes Abnormal, Cardiovascular Disorder, Change Of Bowel Habit, Colitis Ischaemic
on Dec 01, 2008 Female patient from UNITED STATES , 60 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain lower, acidosis, anaemia, blood alkaline phosphatase increased, blood calcium increased, blood electrolytes abnormal, cardiovascular disorder, change of bowel habit, colitis ischaemic. Lotronex dosage: 0.5 Mg;biw;po. During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), MAXZIDE (View Maxzide Review and Maxzide Label ), RELAFEN (View Relafen Review and Relafen Label ), METROGEL (View Metrogel Review and Metrogel Label ), NULEV (View Nulev Review and Nulev Label ), DARVOCET /00220901/ (View Darvocet /00220901/ Review and Darvocet /00220901/ Label ), DONNATAL (View Donnatal Review and Donnatal Label ). Patient was hospitalized.

5944347-6 | Abdominal Adhesions, Blood Alkaline Phosphatase Increased, Blood Calcium Increased, Colitis Ischaemic, Enterocolitis Infectious, Globulins Increased, Haemorrhage, Impaired Work Ability, Intestinal Congestion
Patient was taking Lotronex (View Usage). Patient had the following side effects: abdominal adhesions, blood alkaline phosphatase increased, blood calcium increased, colitis ischaemic, enterocolitis infectious, globulins increased, haemorrhage, impaired work ability, intestinal congestion on Oct 20, 2008 from UNITED STATES Additional patient health information: Female patient , 60 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Lotronex dosage: 0.5 Mg; Biw; Po. During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), MAXZIDE (View Maxzide Review and Maxzide Label ), RELAFEN (View Relafen Review and Relafen Label ), METROGEL (View Metrogel Review and Metrogel Label ), NULEV (View Nulev Review and Nulev Label ), DARVOCET /00220901/ (View Darvocet /00220901/ Review and Darvocet /00220901/ Label ), DONNATAL (View Donnatal Review and Donnatal Label ). Patient was hospitalized.

5930456-4 | Adverse Reaction, Diarrhoea, Gastroenteritis, Nausea, Urine Odour Abnormal
Adverse event was reported on Oct 06, 2008 by a Female patient taking Lotronex (View Usage) (Dosage: Po) . Location: UNITED STATES , 70 years of age, After Lotronex was administered, patient had the following side effects: adverse reaction, diarrhoea, gastroenteritis (What is gastroenteritis?), nausea (What is nausea?), urine odour abnormal. Patient was hospitalized.

5842744-0 | Abdominal Rigidity, Clostridial Infection
on May 30, 2008 Female patient from UNITED STATES , 48 years of age, weighting 112.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal rigidity, clostridial infection. Lotronex dosage: Po; Po; 2 Mg;bid;po. During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), DONNATAL (View Donnatal Review and Donnatal Label ). Patient was hospitalized.

5712309-X | Colitis Ischaemic
on Apr 03, 2008 Female patient from UNITED STATES , 79 years of age, weighting 212.0 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). Patient had the following side effects: colitis ischaemic. Lotronex dosage: 1 Mg; Qd; Po; Bid; Po. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), MAXZIDE (View Maxzide Review and Maxzide Label ), DIOVANE (View Diovane Review and Diovane Label ), TOPROR (View Topror Review and Topror Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

5611484-5 | Abdominal Pain Upper
Patient was taking Lotronex (View Usage). After Lotronex was administered, patient had the following side effects: abdominal pain upper on Nov 28, 2007 from UNITED STATES Additional patient health information: Female patient , 61 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Lotronex dosage: . During the same period patient was treated with ESTRACE (View Estrace Review and Estrace Label ), ONE A DAY VITAMIN (View One A Day Vitamin Review and One A Day Vitamin Label ), CALCIUM + VITAMIN D (View Calcium + Vitamin D Review and Calcium + Vitamin D Label ).

5611483-3 | Abdominal Pain, Constipation
Adverse event was reported on Nov 13, 2007 by a Male patient taking Lotronex (View Usage) (Dosage: 1mg Twice Per Day) was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED STATES , 47 years of age, weighting 230.4 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), constipation (What is constipation?). During the same period patient was treated with CIALIS (View Cialis Review and Cialis Label ), MICRONASE (View Micronase Review and Micronase Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), EYE DROPS (View Eye Drops Review and Eye Drops Label ).

5611479-1 | Dry Eye, Dry Skin, Dry Throat
on Sep 12, 2007 Female patient from UNITED STATES , 46 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). Patient had the following side effects: dry eye, dry skin, dry throat. Lotronex dosage: 1mg Per Day.

5611478-X | Abdominal Pain Upper
on Sep 05, 2007 Male patient from UNITED STATES , 43 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). After Lotronex was administered, patient had the following side effects: abdominal pain upper. Lotronex dosage: 1mg Per Day.

5611477-8 | Bezoar, Dysphasia, Impaired Gastric Emptying
Patient was taking Lotronex (View Usage). Patient experienced the following unwanted or unexpected effects: bezoar, dysphasia, impaired gastric emptying on Aug 07, 2007 from UNITED STATES Additional patient health information: Female patient , 72 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Lotronex dosage: 1mg Per Day. During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), COUMADIN (View Coumadin Review and Coumadin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PREMARIN (View Premarin Review and Premarin Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ).

5611474-2 | Abdominal Pain Upper, Constipation, Off Label Use, Therapeutic Response Unexpected, Tinnitus
Adverse event was reported on Jul 17, 2007 by a Female patient taking Lotronex (View Usage) (Dosage: ) was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED STATES , 65 years of age, Patient had the following side effects: abdominal pain upper, constipation (What is constipation?), off label use, therapeutic response unexpected, tinnitus (What is tinnitus?). During the same period patient was treated with PAXIL (View Paxil Review and Paxil Label ), PAMINE (View Pamine Review and Pamine Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ).

5611471-7 | Hyperhidrosis
on Jun 11, 2007 Female patient from UNITED STATES , 59 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). After Lotronex was administered, patient had the following side effects: hyperhidrosis. Lotronex dosage: 1mg Twice Per Day. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), HERBS (View Herbs Review and Herbs Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ).

5611470-5 | Diarrhoea
on Nov 09, 2007 Female patient from UNITED STATES , 78 years of age, weighting 88.18 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Lotronex (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea. Lotronex dosage: 1mg Twice Per Day. During the same period patient was treated with COLESTID (View Colestid Review and Colestid Label ), LOMOTIL (View Lomotil Review and Lomotil Label ), IMODIUM (View Imodium Review and Imodium Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), MAPROTILINE (View Maprotiline Review and Maprotiline Label ).

5547223-6 | Blood Glucose Increased, Blood Pressure Increased, Diabetes Mellitus, Faecal Incontinence, Therapeutic Response Decreased
Patient was taking Lotronex (View Usage). Patient had the following side effects: blood glucose increased, blood pressure increased, diabetes mellitus, faecal incontinence, therapeutic response decreased on Dec 03, 2007 from UNITED STATES Additional patient health information: Female patient , 76 years of age, weighting 152.3 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and. Lotronex dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LACTOBACILLUS (View Lactobacillus Review and Lactobacillus Label ).